• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sclerostin: a biomarker for chronic kidney disease and vascular disease with added or independent value?

作者信息

Bosevski Marijan

机构信息

Saints Cyril and Methodius University of Skopje, Skopje, Macedonia.

出版信息

Int Urol Nephrol. 2018 Oct;50(10):1919. doi: 10.1007/s11255-018-1972-0. Epub 2018 Sep 4.

DOI:10.1007/s11255-018-1972-0
PMID:30182292
Abstract
摘要

相似文献

1
Sclerostin: a biomarker for chronic kidney disease and vascular disease with added or independent value?硬化素：一种对慢性肾脏病和血管疾病具有附加价值或独立价值的生物标志物？
Int Urol Nephrol. 2018 Oct;50(10):1919. doi: 10.1007/s11255-018-1972-0. Epub 2018 Sep 4.
2
Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease.慢性肾脏病中血清硬化素与血管钙化及临床结局的关系
Diab Vasc Dis Res. 2018 Mar;15(2):99-105. doi: 10.1177/1479164117742316. Epub 2017 Nov 23.
3
[Sclerostin: a new biomarker of interest in nephrology].[硬化素：肾脏病学中一个新的重要生物标志物]
Ann Biol Clin (Paris). 2015 May-Jun;73(3):305-13. doi: 10.1684/abc.2015.1049.
4
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.透析前慢性肾脏病中的骨保护素和硬化素：血管钙化的潜在相关因素
Nephrol Dial Transplant. 2015 Aug;30(8):1345-56. doi: 10.1093/ndt/gfv081. Epub 2015 Apr 7.
5
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.硬化素作为慢性肾脏病3期和4期血管钙化的一个新关键因素。
Int Urol Nephrol. 2016 Dec;48(12):2043-2050. doi: 10.1007/s11255-016-1379-8. Epub 2016 Jul 27.
6
High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients.高血清硬化蛋白水平与血液透析患者更好的预后相关。
Nephron. 2016;132(3):181-90. doi: 10.1159/000443845. Epub 2016 Feb 19.
7
Sclerostin: Another vascular calcification inhibitor?骨硬化蛋白：另一种血管钙化抑制剂？
J Clin Endocrinol Metab. 2013 Aug;98(8):3221-8. doi: 10.1210/jc.2013-1521. Epub 2013 Jun 20.
8
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?血清硬化蛋白：血液透析患者骨-血管相互作用中缺失的环节？
Osteoporos Int. 2015 Aug;26(8):2165-74. doi: 10.1007/s00198-015-3127-9. Epub 2015 Apr 25.
9
Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients.慢性血液透析患者骨源性生物标志物与血管钙化的关联
Clin Chim Acta. 2016 Jan 15;452:38-43. doi: 10.1016/j.cca.2015.10.031. Epub 2015 Oct 30.
10
Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.血清硬化蛋白水平与腹主动脉钙化相关，并可预测3-5D期慢性肾脏病患者的心血管事件。
Nephrology (Carlton). 2017 Apr;22(4):286-292. doi: 10.1111/nep.12813.

引用本文的文献

1
What is the place of sclerostin in chronic kidney disease, atherosclerosis, and ageing?硬化素在慢性肾脏病、动脉粥样硬化及衰老过程中扮演着怎样的角色？
Int Urol Nephrol. 2019 May;51(5):897-898. doi: 10.1007/s11255-019-02132-2. Epub 2019 Mar 19.

本文引用的文献

1
Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?血清硬化素是否为慢性肾脏病-矿物质和骨异常患者动脉粥样硬化的标志物？
Int Urol Nephrol. 2018 Oct;50(10):1863-1870. doi: 10.1007/s11255-018-1935-5. Epub 2018 Jul 20.
2
Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.硬化蛋白、心血管疾病与死亡率：一项系统评价和荟萃分析
Int Urol Nephrol. 2016 Dec;48(12):2029-2042. doi: 10.1007/s11255-016-1387-8. Epub 2016 Aug 6.
3
Sclerostin levels in uremic patients: a link between bone and vascular disease.
尿毒症患者的硬化素水平：骨骼与血管疾病之间的联系。
Ren Fail. 2016 Jun;38(5):759-64. doi: 10.3109/0886022X.2016.1160207. Epub 2016 Mar 22.
4
Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.维持性血液透析患者血清硬化蛋白水平与颈动脉粥样硬化之间的独立关联。
Clin Kidney J. 2015 Dec;8(6):737-43. doi: 10.1093/ckj/sfv077. Epub 2015 Aug 27.
5
Carotid artery disease in diabetic patients.糖尿病患者的颈动脉疾病
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(3):149-61.
6
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.年龄、性别和骨量与男性及女性循环中硬化素水平的关系。
J Bone Miner Res. 2011 Feb;26(2):373-9. doi: 10.1002/jbmr.217.
7
Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.慢性肾脏病患者中骨与矿物质异常对心血管疾病的影响
Clin J Am Soc Nephrol. 2008 May;3(3):836-43. doi: 10.2215/CJN.02910707. Epub 2008 Mar 5.
8
Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden.非糖尿病受试者胰岛素抵抗与颈动脉内膜中层厚度及狭窄之间的关系。瑞典马尔默一项横断面研究的结果。
Diabet Med. 2000 Apr;17(4):299-307. doi: 10.1046/j.1464-5491.2000.00280.x.